These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 25164639)

  • 1. Factor VIII inhibitors complicating treatment of postoperative bleeding in a dog with hemophilia A.
    O'Kelley BM; Whelan MF; Brooks MB
    J Vet Emerg Crit Care (San Antonio); 2009 Aug; 19(4):381-5. PubMed ID: 25164639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemorrhage and blood loss-induced anemia associated with an acquired coagulation factor VIII inhibitor in a Thoroughbred mare.
    Winfield LS; Brooks MB
    J Am Vet Med Assoc; 2014 Mar; 244(6):719-23. PubMed ID: 24568115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholecystectomy and acquired factor VIII inhibitor coagulopathy.
    Walsh JD; Landercasper J; Bottner WA; Boyd WC
    Am Surg; 2004 Sep; 70(9):815-7. PubMed ID: 15481301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired factor V inhibitors after allogeneic hematopoietic stem cell transplantation in a dog.
    Masciana J; Peterson N; Chretin J
    J Vet Intern Med; 2020 Sep; 34(5):2096-2100. PubMed ID: 32686109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe Hemophilia A in a Male Old English Sheep Dog with a C→T Transition that Created a Premature Stop Codon in Factor VIII.
    Lozier JN; Kloos MT; Merricks EP; Lemoine N; Whitford MH; Raymer RA; Bellinger DA; Nichols TC
    Comp Med; 2016; 66(5):405-411. PubMed ID: 27780008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clearance of cryoprecipitated factor VIII in canine hemophilia A.
    Aufderheide WM; Skinner SF; Kaneko JJ
    Am J Vet Res; 1975 Apr; 36(4 Pt.1):367-70. PubMed ID: 1124873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemophilia with factor VIII and factor IX inhibitors, incidence, bleeding problems and management.
    Mahasandana C; Patharathienskul D; Suvatte V
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():106-12. PubMed ID: 7886549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemophilia A in three unrelated cats.
    Cotter SM; Brenner RM; Dodds WJ
    J Am Vet Med Assoc; 1978 Jan; 172(2):166-8. PubMed ID: 627514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of the intron 22 inversion of the factor VIII gene and inhibitor development in Polish patients with severe hemophilia A.
    Sawecka J; Skulimowska J; Windyga J; Lopaciuk S; Kościelak J
    Arch Immunol Ther Exp (Warsz); 2005; 53(4):352-6. PubMed ID: 16088320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Life-threatening bleeding after dental extraction in a hemophilia A patient with inhibitors to factor VIII: a case report.
    Heiland M; Weber M; Schmelzle R
    J Oral Maxillofac Surg; 2003 Nov; 61(11):1350-3. PubMed ID: 14613094
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical outcome after diagnosis of hemophilia A in dogs.
    Aslanian ME; Sharp CR; Rozanski EA; de Laforcade AM; Rishniw M; Brooks MB
    J Am Vet Med Assoc; 2014 Sep; 245(6):677-83. PubMed ID: 25181272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of hemophilia with immunologic inhibitor of factor VIII by using "activated" coagulant fractions].
    Sultan Y; Brouet JC
    Nouv Presse Med; 1975 Oct; 4(36):2571-4. PubMed ID: 1081682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid decrease in high titer of factor VIII inhibitors upon immunosuppressive treatment in severe postpartum acquired hemophilia A.
    Pejsa V; Grgurević I; Kusec R; Gaćina P
    Croat Med J; 2004 Apr; 45(2):213-6. PubMed ID: 15103761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dental treatment for a hemophilia A patient with circulating antibodies to factor VIII.
    Croll TP; Macko DJ; Hoyer LW
    J Pedod; 1978; 2(4):344-52. PubMed ID: 120892
    [No Abstract]   [Full Text] [Related]  

  • 15. Severe acquired hemophilia with factor VIII inhibition associated with acetaminophen and chlorpheniramine.
    Famularo G; De Maria S; Minisola G; Nicotra GC
    Ann Pharmacother; 2004 Sep; 38(9):1432-4. PubMed ID: 15266042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Perioperative use of recombinant activated factor VII (rF VIIa) in a patient with hemophilia A having inhibitors].
    Kawasaki Y; Saeki N; Kawamoto M; Yuge O; Fujii T
    Masui; 2005 Aug; 54(8):926-8. PubMed ID: 16104555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitor antibodies to factor VIII and factor IX: management.
    Lusher JM
    Semin Thromb Hemost; 2000; 26(2):179-88. PubMed ID: 10919411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors.
    Santagostino E; Morfini M; Rocino A; Baudo F; Scaraggi FA; Gringeri A
    Thromb Haemost; 2001 Oct; 86(4):954-8. PubMed ID: 11686352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemophilia A in a female dog.
    Murtaugh RJ; Dodds WJ
    J Am Vet Med Assoc; 1988 Aug; 193(3):351-2. PubMed ID: 3141324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The development of homologous (canine/anti-canine) antibodies in dogs with haemophilia A (factor VIII deficiency): a ten-year longitudinal study.
    Tinlin S; Webster S; Giles AR
    Thromb Haemost; 1993 Jan; 69(1):21-4. PubMed ID: 8446933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.